Mirador Strategies provides commercialization and business development consulting to growing
life science companies. A particular focus for Mirador Strategies is on the unique aspects of commercializing biotherapeutics.
Mirador means "outlook" or "vantage point" and exemplifies the clear strategic perspective
offered to clients.
Dave Boyden, President of Mirador Strategies, is a seasoned commercial executive with more than
25 years experience in the biopharmaceutical industry, including R&D, business development, sales and marketing.
Before founding Mirador Strategies in 2005, he worked for both large and small companies and managed some of the
biggest biotech brands, including EPOGEN and Aranesp.
